Merck Serono S.A. Sustainability Profile
Merck Serono S.A., a prominent biopharmaceutical company, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 2007 as the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, it has established itself as a leader in the healthcare industry, focusing on innovative therapies in areas such as oncology, neurology, and fertility. The company is renowned for its unique portfolio of products, including cutting-edge biologics and specialty pharmaceuticals that address unmet medical needs. Merck Serono's commitment to research and development has led to significant advancements in personalised medicine, positioning it as a key player in the global market. With a strong emphasis on scientific excellence and patient-centric solutions, Merck Serono continues to achieve notable milestones in the biopharmaceutical landscape.
DitchCarbon Score
How does Merck Serono S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck Serono S.A.'s score of 62 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merck Serono S.A., headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as no emissions figures are available. However, the company is part of a corporate family relationship with Merck KGaA, which provides a framework for its climate commitments and initiatives. As a current subsidiary of Merck KGaA, Merck Serono S.A. inherits climate-related targets and performance metrics from its parent company. Merck KGaA has established science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets are cascaded down to Merck Serono S.A. and reflect the company's commitment to sustainability and climate action. While specific reduction targets for Merck Serono S.A. are not detailed, the overarching initiatives from Merck KGaA include commitments to reduce Scope 1 and Scope 2 emissions, as well as engaging in efforts to address Scope 3 emissions through supply chain management and product lifecycle assessments. In summary, while Merck Serono S.A. does not currently report its own emissions data, it aligns with the climate commitments and reduction strategies set forth by its parent company, Merck KGaA, demonstrating a commitment to addressing climate change within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2006 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 352,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | - | 000,000,000 |
| Scope 2 | 402,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Merck Serono S.A.'s Industry?
How Carbon Intensive is Merck Serono S.A.'s Location?
Merck Serono S.A.'s Scope 3 Categories Breakdown
Merck Serono S.A.'s Scope 3 emissions, which decreased by 12% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
Merck Serono S.A.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merck Serono S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
